G-protein coupled receptors, also known as seven-(pass)-transmembrane receptors, are a type of membrane receptor located in the cell membrane. Their primary function is to bind extracellular chemicals and transmit signals from these substances to intracellular molecules. Representing the largest family of membrane proteins, GPCRs play a pivotal role in mediating cellular responses to hormones and neurotransmitters. They are responsible for functions such as vision, olfaction, and taste.
The main offerings associated with G-protein-coupled receptors include cell lines, detection kits, cell culture reagents, and ligands. A cell line refers to a selected uniform cell culture derived from a population of cells typically sourced from a homogeneous tissue. Various types of assays, including camp functional assays, calcium functional assays, B-arrestin functional assays, radioligand binding and GTPYS functional assays, internalization assays, and trafficking assays, are employed in diverse applications. These applications span areas such as cancer research, CNS research, metabolic research, cardiovascular research, inflammation research, respiratory research, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The G-protein-coupled receptors market research report is one of a series of new reports from The Business Research Company that provides G-protein-coupled receptors market statistics, including the G-protein-coupled receptors industry global market size, regional shares, competitors with a G-protein-coupled receptors market share, detailed G-protein-coupled receptors market segments, G-protein-coupled receptors market trends, and opportunities, and any further data you may need to thrive in the G-protein-coupled receptors industry. This G-protein-coupled receptors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The g-protein coupled receptors market size has grown strongly in recent years. It will grow from $3.2 billion in 2024 to $3.4 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to drug discovery advances, FDA approvals, genomic discoveries, emerging markets, market consolidation, growing aging population.
The g-protein coupled receptors market size is expected to see strong growth in the next few years. It will grow to $4.44 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to personalized medicine, increased focus on rare diseases, artificial intelligence in drug discovery, patient-centric drug development, environmental and social factors, biosimilar market growth. Major trends in the forecast period include biotechnology advancements, increased r&d investment, technological innovations, collaborations and partnerships, digital therapeutics.
The forecast of 6.9% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. drug discovery by increasing costs for fluorescent ligand kits and cryo-EM systems imported from Canada and Germany, potentially slowing pharmaceutical development timelines by 8-12 months while increasing research and development (R&D) costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of cancer is expected to drive the growth of the G-protein-coupled receptors (GPCRs) market in the coming years. Cancer is a disease characterized by the uncontrolled spread of abnormal cells, which can invade surrounding tissues and disseminate through the body's lymphatic and vascular systems. GPCRs play a crucial role in regulating processes that are key to cancer progression, such as proliferative signaling, replicative immortality, evasion of growth suppressors, resistance to apoptosis, and activation of invasion and metastasis. For example, in January 2023, the American Cancer Society, a US-based professional organization, reported that there were 1,958,310 new cancer cases diagnosed in the United States in 2023, an increase from the estimated 1.9 million new cases in 2022. Thus, the rising prevalence of cancer is significantly driving the growth of the G-protein-coupled receptors market.
Rising healthcare expenditures are expected to drive the growth of the G-protein-coupled receptors (GPCRs) market. Healthcare expenditures encompass the total spending on healthcare-related services, products, and activities over a specific period, whether at the individual, community, national, or global level. Increased healthcare spending typically results in the expansion of healthcare services and facilities, which, in turn, leads to a higher demand for GPCR-targeted drugs as healthcare providers seek advanced and innovative treatments for various diseases and conditions. For instance, in 2022, the Office for National Statistics, a UK-based national statistics organization, reported that UK healthcare expenditure reached approximately $354.88 billion (£283 billion), marking a nominal increase of 0.7% compared to 2021. Therefore, the rise in healthcare expenditures is expected to significantly contribute to the growth of the G-protein-coupled receptors market.
A prominent trend gaining traction in the G-protein-coupled receptor (GPCR) market is the strategic investment to advance GPCR screening and antibody development. Leading companies in the GPCR sector are actively seeking investments to propel the development of drugs and medication technologies associated with GPCR-related diseases. For example, in February 2023, LifeArc Ventures, a venture capital firm based in the UK, invested $16 million in Maxion Therapeutics, a UK-based drug discovery company. This investment aims to advance antibody development for previously untreatable ion channel and GPCR-driven disorders, leveraging the proprietary KnotBody technology for the development of antibody therapeutics targeting ion channels and GPCRs.
Major companies in the G-protein-coupled receptors (GPCRs) market are initiating Initial Public Offerings (IPOs) to enhance their development of drugs targeting GPCRs. This move aims to accelerate research and development, advance clinical trials, and introduce innovative therapies for various diseases, including cancer, neurological disorders, and metabolic conditions. The funds raised from these IPOs will primarily support the development of the companies' lead product candidates aimed at chronic metabolic and pulmonary diseases. In particular, the proceeds are designated for advancing their glucagon-like peptide-1 receptor (GLP-1R) agonist program, which focuses on diabetes and obesity treatments. For example, in February 2023, Structure Therapeutics Inc., a US-based company, successfully completed its IPO, raising $161 million to further its development of GPCR-based therapeutics. The company offered 10,740,000 American depositary shares (ADSs) at $15.00 per ADS, significantly exceeding its initial projections. The shares began trading on the Nasdaq Global Market under the ticker symbol "GPCR."
In December 2023, Danaher Corporation, a US-based company, acquired Abcam Plc for an undisclosed amount. This acquisition is intended to enhance Danaher's portfolio by integrating Abcam's expertise in G-protein-coupled receptors (GPCRs). Abcam Plc is a UK-based company that specializes in the provision of GPCRs.
Major companies operating in the G-protein coupled receptors market include Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline Plc, Danaher Corporation, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Thermo Fisher Scientific Inc., Perkin Elmer Inc., Qiagen N.V., Bio-Techne Corporation, Abcam PLC, Cara Therapeutics Inc., Sosei Heptares Ltd., Eurofins DiscoverX Corporation, Crinetics Pharmaceuticals Inc., Domain Therapeutics SA, Addex Pharmaceuticals Ltd., Escient Pharmaceuticals Inc., Structure Therapeutics, Septerna
North America was the largest region in the G-protein coupled receptors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the g-protein coupled receptors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the g-protein coupled receptors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The G-protein-coupled receptors market consists of revenues earned by entities by providing GPCR screening and profiling services, GPCR antibodies and immunoassays, hormones visual control. The market value includes the value of related goods sold by the service provider or included within the service offering. The G-protein-coupled receptors market also includes sales of adenosine, serotonin, and metabotropic receptor. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
G-Protein Coupled Receptors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on g-protein coupled receptors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for g-protein coupled receptors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The g-protein coupled receptors market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product: Cell Lines; Detection Kits; Cell Culture Reagents; Ligands
- 2) By Assay: CAMP Functional Assays; Calcium Functional Assays; B-Arrestin Functional Assays; Radioligand Binding And GTPYS Functional Assays; Internalization Assays; Trafficking Assays
- 3) By Applications: Cancer Research; CNS Research; Metabolic Research; Cardiovascular Research; Inflammation Research; Respiratory Research; Other Applications
- Subsegments:
- 1) By Cell Lines: GPCR-Expressing Cell Lines; Stable And Transient Cell Lines
- 2) By Detection Kits: ELISA Kits; High-Throughput Screening Kits; Reporter Gene Assays
- 3) By Cell Culture Reagents: Media And Supplements; Transfection Reagents; Growth Factors
- 4) By Ligands: Agonists; Antagonists; Inverse Agonists
- Companies Mentioned: Pfizer Inc.; Roche Holding AG; AbbVie Inc.; Bayer AG; Novartis International AG; Sanofi SA; Bristol-Myers Squibb Company; AstraZeneca Plc; GlaxoSmithKline Plc; Danaher Corporation; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Merck KGaA; Boehringer Ingelheim; Teva Pharmaceutical Industries Ltd.; Daiichi Sankyo Company Limited; Thermo Fisher Scientific Inc.; Perkin Elmer Inc.; Qiagen N.V.; Bio-Techne Corporation; Abcam PLC; Cara Therapeutics Inc.; Sosei Heptares Ltd.; Eurofins DiscoverX Corporation; Crinetics Pharmaceuticals Inc.; Domain Therapeutics SA; Addex Pharmaceuticals Ltd.; Escient Pharmaceuticals Inc.; Structure Therapeutics; Septerna
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. G-Protein Coupled Receptors Market Characteristics
3. G-Protein Coupled Receptors Market Trends And Strategies
4. G-Protein Coupled Receptors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global G-Protein Coupled Receptors Growth Analysis And Strategic Analysis Framework
- 5.1. Global G-Protein Coupled Receptors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global G-Protein Coupled Receptors Market Growth Rate Analysis
- 5.4. Global G-Protein Coupled Receptors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global G-Protein Coupled Receptors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global G-Protein Coupled Receptors Total Addressable Market (TAM)
6. G-Protein Coupled Receptors Market Segmentation
- 6.1. Global G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cell Lines
- Detection Kits
- Cell Culture Reagents
- Ligands
- 6.2. Global G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- CAMP Functional Assays
- Calcium Functional Assays
- B-Arrestin Functional Assays
- Radioligand Binding and GTPYS Functional Assays
- Internalization Assays
- Trafficking Assays
- 6.3. Global G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cancer Research
- CNS Research
- Metabolic Research
- Cardiovascular Research
- Inflammation Research
- Respiratory Research
- Other Applications
- 6.4. Global G-Protein Coupled Receptors Market, Sub-Segmentation Of Cell Lines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- GPCR-Expressing Cell Lines
- Stable And Transient Cell Lines
- 6.5. Global G-Protein Coupled Receptors Market, Sub-Segmentation Of Detection Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- ELISA Kits
- High-Throughput Screening Kits
- Reporter Gene Assays
- 6.6. Global G-Protein Coupled Receptors Market, Sub-Segmentation Of Cell Culture Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Media And Supplements
- Transfection Reagents
- Growth Factors
- 6.7. Global G-Protein Coupled Receptors Market, Sub-Segmentation Of Ligands, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Agonists
- Antagonists
- Inverse Agonists
7. G-Protein Coupled Receptors Market Regional And Country Analysis
- 7.1. Global G-Protein Coupled Receptors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global G-Protein Coupled Receptors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific G-Protein Coupled Receptors Market
- 8.1. Asia-Pacific G-Protein Coupled Receptors Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China G-Protein Coupled Receptors Market
- 9.1. China G-Protein Coupled Receptors Market Overview
- 9.2. China G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India G-Protein Coupled Receptors Market
- 10.1. India G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan G-Protein Coupled Receptors Market
- 11.1. Japan G-Protein Coupled Receptors Market Overview
- 11.2. Japan G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia G-Protein Coupled Receptors Market
- 12.1. Australia G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia G-Protein Coupled Receptors Market
- 13.1. Indonesia G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea G-Protein Coupled Receptors Market
- 14.1. South Korea G-Protein Coupled Receptors Market Overview
- 14.2. South Korea G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe G-Protein Coupled Receptors Market
- 15.1. Western Europe G-Protein Coupled Receptors Market Overview
- 15.2. Western Europe G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK G-Protein Coupled Receptors Market
- 16.1. UK G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany G-Protein Coupled Receptors Market
- 17.1. Germany G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France G-Protein Coupled Receptors Market
- 18.1. France G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy G-Protein Coupled Receptors Market
- 19.1. Italy G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain G-Protein Coupled Receptors Market
- 20.1. Spain G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe G-Protein Coupled Receptors Market
- 21.1. Eastern Europe G-Protein Coupled Receptors Market Overview
- 21.2. Eastern Europe G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia G-Protein Coupled Receptors Market
- 22.1. Russia G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America G-Protein Coupled Receptors Market
- 23.1. North America G-Protein Coupled Receptors Market Overview
- 23.2. North America G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA G-Protein Coupled Receptors Market
- 24.1. USA G-Protein Coupled Receptors Market Overview
- 24.2. USA G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada G-Protein Coupled Receptors Market
- 25.1. Canada G-Protein Coupled Receptors Market Overview
- 25.2. Canada G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America G-Protein Coupled Receptors Market
- 26.1. South America G-Protein Coupled Receptors Market Overview
- 26.2. South America G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil G-Protein Coupled Receptors Market
- 27.1. Brazil G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East G-Protein Coupled Receptors Market
- 28.1. Middle East G-Protein Coupled Receptors Market Overview
- 28.2. Middle East G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa G-Protein Coupled Receptors Market
- 29.1. Africa G-Protein Coupled Receptors Market Overview
- 29.2. Africa G-Protein Coupled Receptors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa G-Protein Coupled Receptors Market, Segmentation By Assay, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa G-Protein Coupled Receptors Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. G-Protein Coupled Receptors Market Competitive Landscape And Company Profiles
- 30.1. G-Protein Coupled Receptors Market Competitive Landscape
- 30.2. G-Protein Coupled Receptors Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
31. G-Protein Coupled Receptors Market Other Major And Innovative Companies
- 31.1. Sanofi SA
- 31.2. Bristol-Myers Squibb Company
- 31.3. AstraZeneca Plc
- 31.4. GlaxoSmithKline Plc
- 31.5. Danaher Corporation
- 31.6. Takeda Pharmaceutical Company Limited
- 31.7. Eli Lilly and Company
- 31.8. Merck KGaA
- 31.9. Boehringer Ingelheim
- 31.10. Teva Pharmaceutical Industries Ltd.
- 31.11. Daiichi Sankyo Company Limited
- 31.12. Thermo Fisher Scientific Inc.
- 31.13. Perkin Elmer Inc.
- 31.14. Qiagen N.V.
- 31.15. Bio-Techne Corporation
32. Global G-Protein Coupled Receptors Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The G-Protein Coupled Receptors Market
34. Recent Developments In The G-Protein Coupled Receptors Market
35. G-Protein Coupled Receptors Market High Potential Countries, Segments and Strategies
- 35.1 G-Protein Coupled Receptors Market In 2029 - Countries Offering Most New Opportunities
- 35.2 G-Protein Coupled Receptors Market In 2029 - Segments Offering Most New Opportunities
- 35.3 G-Protein Coupled Receptors Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
